Brief: Kinnate Biopharma Inc. Announces Third Quarter 2022 Financial Results And Recent Corporate Updates
10/11/2022 21:36
Nov 10 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* . ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND
RECENT
CORPORATE UPDATES
* KINNATE BIOPHARMA - CASH, CASH EQUIVALENTS AND INVESTMENTS
OF
$262.1 MILLION AS OF SEP 30, 2022; CASH RUNWAY EXPECTED TO FUND
OPERATIONS INTO MID-2024
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.70
* Q3 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7PXvNQ
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview